AG
NVAX icon

Aperio Group’s Novavax NVAX Stock Holding History

Aperio Group’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$1.9M Buy
17,073
+936
+6% +$99.5K 0.01% 1261
2020
Q3 		$1.75M Buy
16,137
+2,944
+22% +$359K 0.01% 1180
2020
Q2 		$1.1M Buy
13,193
+2,752
+26% +$105K ﹤0.01% 1368
2020
Q1 		$142K Buy
+10,441
New +$88.3K ﹤0.01% 2157
2019
Q3 		– Sell
-5,238
Closed -$31K – 2605
2019
Q2 		$31K Buy
5,238
+1,879
+56% +$14.8K ﹤0.01% 2622
2019
Q1 		$37K Sell
3,359
-1,128
-25% -$35.6K ﹤0.01% 2273
2018
Q4 		$165K Buy
4,487
+304
+7% +$11.8K ﹤0.01% 2171
2018
Q3 		$157K Sell
4,183
-1,466
-26% -$41.3K ﹤0.01% 2217
2018
Q2 		$151K Sell
5,649
-760
-12% -$25.7K ﹤0.01% 2197
2018
Q1 		$269K Buy
6,409
+643
+11% +$25.8K ﹤0.01% 2004
2017
Q4 		$143K Buy
5,766
+3,158
+121% +$77K ﹤0.01% 2182
2017
Q3 		$59K Buy
2,608
+1,454
+126% +$32.6K ﹤0.01% 2199
2017
Q2 		$27K Sell
1,154
-451
-28% -$8.85K ﹤0.01% 2208
2017
Q1 		$41K Buy
1,605
+130
+9% +$3.58K ﹤0.01% 2135
2016
Q4 		$37K Buy
1,475
+291
+25% +$8.49K ﹤0.01% 2110
2016
Q3 		$49K Buy
1,184
+128
+12% +$16.5K ﹤0.01% 2042
2016
Q2 		$153K Buy
1,056
+194
+23% +$22.2K ﹤0.01% 1923
2016
Q1 		$89K Sell
862
-334
-28% -$35.8K ﹤0.01% 1980
2015
Q4 		$201K Buy
1,196
+269
+29% +$41.4K ﹤0.01% 1820
2015
Q3 		$131K Buy
927
+152
+20% +$34.1K ﹤0.01% 1832
2015
Q2 		$173K Hold
775
– – ﹤0.01% 1895
2015
Q1 		$128K Hold
775
– – ﹤0.01% 1898
2014
Q4 		$92K Buy
775
+44
+6% +$4.6K ﹤0.01% 1838
2014
Q3 		$61K Buy
731
+158
+28% +$14.3K ﹤0.01% 1715
2014
Q2 		$53K Buy
+573
New +$50.4K ﹤0.01% 1710

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Aperio Group's NVAX Position: Q4 2020 in Review

Aperio Group increased its Novavax (NVAX) stake by 5.8% in Q4 2020, buying an estimated $99.5K and bringing the position to 17,073 shares worth $1.9M. The position accounts for 0.01% of the portfolio, ranked #1261.

Aperio Group first reported a position in NVAX in Q2 2014 and has held it in 25 quarters since. 347 funds tracked by Wall St. Rank hold NVAX as of Q4 2020.

  • Aperio Group held 17,073 shares of Novavax worth $1.9M as of Q4 2020.
  • Aperio Group bought 936 Novavax shares in Q4 2020, an estimated $99.5K.
  • Novavax made up 0.01% of Aperio Group's portfolio in Q4 2020, its #1261 holding.
  • Aperio Group first reported a position in Novavax in Q2 2014 and has held it in 25 quarters since.
  • 347 funds tracked by Wall St. Rank held Novavax as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.